10% Year-End Discount on Crown Biosciences OmniScreen™ and OmniPanel™

Crown Bioscience stands out as a leading global contract research organization, renowned for its cutting-edge in vivo, in vitro, and ex vivo preclinical models. Opt for Crown Bioscience to meet your oncology and immuno-oncology requirements with high-quality results.

Crown Bioscience is offering a 10% year-end discount on their OmniScreen™ and 2D and 3D cell line in vitro work services. Be sure to include Crown Bioscience in your request here so we can apply your discount. Requests must be submitted by December 31, 2023. As an Advantage Supplier, 100% of the transaction fees will be covered by Crown Biosciences. Don’t miss out on this opportunity!

About OmniScreen™ and Omni Panel

OmniScreen™ assesses the efficacy and potency of oncology drug candidates through an initial screen with Crown Biosciences’ large-scale cancer cell line panels. Service includes:

• Real-time Readouts
• Embedded Quality Controls
• Focused Screening Panels
• Fixed Option Screening Schedules
• Advanced Assay Setups
• Combination Assays and Screens
• Bioinformatics Supports
• Historical Data

Find more information about OmniScreen™ here.

OmniPanel™ is a comprehensive solution for cell line screening needs, available in 2D or 3D spheroid format.

Multiparameter Screening: Delivers comprehensive, rapid results for drug combination evaluations. Features:

• Analyze and report on two-drug combination effects
• Understand the syngergic, antagonistic, or additive impact of drug combinations
• Leverage Crown Biosciences’ CrownSyn™ bioninformatics service for data interpretation

Functional Assay Services. Includes:

• High throughput cytotoxicity screening
• In vitro drug combination studies
• 3D clonogenic assays
• Target validation studies
• Adhesion, migration, and invasion assays
• Angiogenesiss assays and apoptosis studies
• ADCC and CDC analyses, cell cycle analysis
• Pharmacodynamics / pharmacokinetcs analysis

Find more information about OmniPanel™ here.